Oxycontin maker Purdue Pharma filed for Chapter 11 bankruptcy last night. The company has also reached a deal with 24 states that accused the company of fueling the U.S. opioid crisis. Yahoo Finance's Dan Roberts, Julia La Roche, Brian Cheung, and Alexis Keenan break down the details of the settlement.
The battery start-up might reach its ambitions sooner than expected.
This historically flawless predictive tool has accurately foreshadowed what's to come for the U.S. economy since 1959.
There is no shortage of reasons to be bearish about this business.
These three low-volatility, dividend-growth stocks offer the potential to rebound while trading near decade-low valuations.
Energy Transfer has a huge 8% yield, but you'd be better off with this still massive, 7.3%-yielding alternative.
While the energy sector has gotten off to a hot start this year, opportunities in master limited partnerships (MLP) stick out from the crowd.
Multiple growth drivers and strong secular tailwinds should combine to drive this artificial intelligence (AI) pioneer higher.
Did lawmakers really pilfer Social Security's piggy bank? Here's the truth.
Intel was hit with more bad news that has enormous implications for investors.
Identifying great businesses is vital for positive investment returns, but buying at the right price matters as well.